QSAR study of dipeptidyl peptidase-4 inhibitors based on the Monte Carlo method

Be aware of error measures. Further studies on validation of predictive QSAR models

(2016) Kunal Roy et al.   CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS

Application of SMILES Notation Based Optimal Descriptors in Drug Discovery and Design

(2015) Aleksandar Veselinovic et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Recent approaches to medicinal chemistry and therapeutic potential of dipeptidyl peptidase-4 (DPP-4) inhibitors

(2014) Bhumika D. Patel et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

3D-QSAR studies of dipeptidyl peptidase-4 inhibitors using various alignment methods

(2014) Bhumika D. Patel et al.   MEDICINAL CHEMISTRY RESEARCH

QSAR as a random event: Modeling of nanoparticles uptake in PaCa2 cancer cells

(2013) Andrey A. Toropov et al.   CHEMOSPHERE

QSAR Modeling: Where Have You Been? Where Are You Going To?

(2013) Artem Cherkasov et al.   JOURNAL OF MEDICINAL CHEMISTRY

QSAR studies on pyrrolidine amides derivatives as DPP-IV inhibitors for type 2 diabetes

(2013) Xiaoyan Yang et al.   MEDICINAL CHEMISTRY RESEARCH

Cationic Lipids Containing Cyclen and Ammonium Moieties as Gene Delivery Vectors

(2012) Qing-Dong Huang et al.   Chemical Biology & Drug Design

An Integrated Drug Development Approach Applying Topological Descriptors

(2012) Alan Talevi et al.   Current Computer-Aided Drug Design

3D-QSAR and docking studies of arylmethylamine-based DPP IV inhibitors

(2012) Chaoyi Jiang et al.   Acta Pharmaceutica Sinica B

Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554

(2011) Hironobu Maezaki et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Comparative QSARs for antimalarial endochins: Importance of descriptor-thinning and noise reduction prior to feature selection

(2011) Probir Kumar Ojha et al.   CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS

Further exploring rm2 metrics for validation of QSPR models

(2011) Probir Kumar Ojha et al.   CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS

CORAL: Building up the model for bioconcentration factor and defining it’s applicability domain

(2011) A.A. Toropov et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Comparative Studies on Some Metrics for External Validation of QSPR Models

(2011) Kunal Roy et al.   Journal of Chemical Information and Modeling

Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary

(2010) S. R. Colberg et al.   DIABETES CARE

Molecular docking and 3D-QSAR studies on β-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors

(2010) Yan-Ke Jiang   JOURNAL OF MOLECULAR MODELING

CoMFA and CoMSIA of diverse pyrrolidine analogues as dipeptidyl peptidase IV inhibitors: active site requirements

(2010) Vanangamudi Murugesan et al.   MOLECULAR DIVERSITY

Exercise and type 2 diabetes mellitus—good for body and mind?

(2010) Niels Jessen et al.   Nature Reviews Endocrinology

3D-QSAR studies on triazolopiperazine amide inhibitors of dipeptidyl peptidase-IV as anti-diabetic agents

(2009) U. Saqib et al.   SAR AND QSAR IN ENVIRONMENTAL RESEARCH

Discovery of DPP IV Inhibitors by Pharmacophore Modeling and QSAR Analysis followed by in silico Screening

(2008) Ihab M. Al-masri et al.   ChemMedChem

Exploring the impact of size of training sets for the development of predictive QSAR models

(2007) Partha Pratim Roy et al.   CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS

A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors

(2007) I.-Lin Lu et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY